Countries that struggled to acquire COVID-19 vaccines have not forgotten the inequity, and are reminding pharma giants that they shouldn’t either

Never underestimate the meticulousness with which authorities operate or the standards that businesses are expected to adhere to.

Almirall’s humanized monoclonal antibody treatment for psoriasis brings positivity for patients

Watch our roundtable discussion featuring experts from TrakCel, Ori Biotech, ScaleReady, and RoslinCT

Researchers are working on ways to introduce nanoscale artificial life-forms to viruses with the aim of mimicking the human immune system

Deputy editor Rob Coker recalls his trip to the labs of Caszyme, Vilnius, where he spoke with CEO Monika Paule about the potential of genome editing

Climate change is real – it’s happening now – and it will take an awesome effort from the pharma industry to mitigate it

In the second episode of the We Salute You series, we focus on much maligned Hungarian physician Ignaz Semmelweis

The science behind space-based medicine is a bit of a slow-burner, but it’s on the launchpad

Watch our roundtable discussion featuring experts from Terumo Blood and Cell Technologies, Orgenesis, ScaleReady, and BioBridge Global